The supermarket ‘antidepressant' in your spice rack
'However, St John's Wort and saffron more often showed effects compared to placebo, and similar results to prescription antidepressants,' Frost wrote in an accompanying editorial in Frontiers of Pharmacology.
Frost, we should note, is a herbal medicine practitioner herself; the first of many caveats we'll cover on this study.
It's not surprising St John's Wort showed a strong effect. A Cochrane review, the gold-standard for scientific evidence, found the flower extract could treat symptoms of depression as effectively as antidepressants back in 2008.
Ian Hickie, professor of psychiatry and co-director of health and policy at the University of Sydney's Brain and Mind Centre, said St John's Wort is known to be pharmacologically similar to a weak SSRI (selective serotonin reuptake inhibitor) antidepressant medication. 'It should be seen as a 'medicine' and not simply a natural product,' he says.
Hickie noted that many of the other natural interventions weighed up in the review were tested on subclinical depression, not the severe illness conventional antidepressants are aimed at, which is important to consider when interpreting the results.
The review also didn't analyse the statistical power of each trial's results, which most modern meta-analyses do, and instead simply collated the number of positive and negative experiments on each substance.
That doesn't take us far, particularly because most of the trials included in the review had small sample sizes.
So where does that leave us with the claim that saffron, alongside St John's Wort, could be as potent as a prescription antidepressant?
A narrow evidence base
Eighteen studies on saffron were included in the review. Most found the substance improved people's mood and alleviated depression at least as well as conventional medication.
But, reading the studies one by one, something caught my eye: at least half were co-authored by the same researcher.
Further, all but one of the studies emerged from a small group of research organisations in Iran. That's not surprising; Iran produces 90 per cent of the world's saffron, so naturally the country's scientists would lead experiments on its therapeutic potential.
What it does show, however, is that the experimental landscape for saffron is very concentrated. To be confident that a certain new drug or intervention works, ideally, you want labs across many countries running experiments with a range of settings and participants of different ethnicities.
It's safe to say the evidence base, as it stands, is narrow.
The one study referenced in the paper completed outside of Iran was an Australian one led by Dr Adrian Lopresti, which found saffron extract could help reduce depressive symptoms in people already taking a pharmaceutical antidepressant.
Lopresti, who's the managing director of Clinical Trials Australia, also just published a new paper that marks the largest study to date on saffron and mood, with 202 participants.
The trial found 72.3 per cent of participants with depressive symptoms (not clinical depression) taking saffron extract significantly improved compared to 54.3 per cent of people on a placebo.
Scientists believe saffron could address chemical issues associated with depression, which include problems with neurotransmitters, high inflammatory blood markers, and low levels of antioxidants.
'Saffron is an anti-inflammatory, it's an antioxidant, and it impacts on neurotransmitters too, so it probably works through those different mechanisms,' Lopresti says.
Fine print and industry funding
But these Australian studies, too, come with a crucial caveat: they were funded by a biotech company that sells saffron supplements.
'I think what you've got to really do is not hedge your bets on just one single study,' Lopresti says when I ask how people should interpret studies funded by industry. 'Has it been replicated across the world with different research organisations?'
Loading
Jerome Sarris, professor of integrative mental health at the NICM medical research institute, said it's important to note potential conflicts of interest. But they can be managed in placebo-controlled, double-blind studies – where participants and experimenters don't know who's on the placebo – as long as data is analysed independently of industry.
'Of course, read the fine print, look at the conflict of interest and weigh that up in your own mind. But I would also say universities are pretty good in terms of having safeguards around conflict of interest management,' he says.
People considering supplements for mood or mental illness should seek professional health advice. Herbs and other supplements can interact with other medications. St John's Wort, for example, can lead to a potentially life-threatening increase in serotonin when combined with some antidepressants.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Courier-Mail
7 minutes ago
- Courier-Mail
Shelly Horton on the dark truth about perimenopause
Don't miss out on the headlines from Celebrity Life. Followed categories will be added to My News. When Shelly Horton found herself in the ICU after an ablation in 2020 (a simple procedure to stop persistent bleeding), it didn't cross her mind that it might be a symptom of perimenopause. Nor did she join the dots between a raft of sudden physical and mental changes – heart palpitations, increased body temperature, 'brain fog', and debilitating depression – and perimenopause. The now 51-year-old says she'd never heard the word before, and instead was told by doctors that it might be cancer and was sent for an ultrasound. 'They said, 'Great news, you haven't got cancer. You must be stressed and maybe you should take up a hobby',' Horton tells Stellar. 'I drove home in tears, blaming myself, and didn't go and see another doctor for nine months.' Media personality Shelly Horton has opened up about her health journey through perimenopause. Picture: Daniel Nadel for Stellar It wasn't until the TV presenter consulted with her friend, Dr. Ginny Mansberg, whom she met as a fellow panellist on Seven's Sunrise in 2008, that she was able to make sense of her suffering. Before that defining moment, she hadn't considered herself in the target market. 'I thought menopause was for women in their late 50s, their period stopped and they got hot flushes,' she explains. 'I had that stereotype in my brain of grey-haired old ladies clutching their pearls and fanning themselves. 'I was like, 'I'm a fox. I'm way too young and fabulous.' 'I didn't understand that perimenopause can last 10 years so, in fact, I was right in the average age group.' Once she started to feel better, Horton got mad. Specifically about the menopause cone of silence which perpetuates the dearth of knowledge and poor treatment options for women. 'We've been taught by our mothers and past generations that it's just women's problems so you keep it to yourself,' she says. 'A heads-up would have been nice. I felt like the sisterhood let me down. 'Secret women's business holds women back. This whole 'soldier on' of the boomer generation, I'm like, 'No, I'm Gen X. We're going to get loud about this.'' 'I didn't understand why anyone cared about my uterus and what I did with it.' Picture: Daniel Nadel for Stellar In 2023, Horton shared her experience at the first parliamentary roundtable on menopause alongside respected experts – the first time 'menopause' had been mentioned in the Australian Parliament. It sparked a Senate inquiry, with Horton inadvertently becoming a spokesperson on perimenopause. It's not the first time Horton has led the charge on de-stigmatising taboo topics for women. When she 'bravely' wrote about her decision to stay 'child free' in 2013, she copped a pile-on from dissenters and was trolled on social media. But she takes heart in knowing it started a national conversation. 'I had comments like, 'A woman who doesn't want kids is not a real woman. She's a waste of a uterus.' It was awful. I didn't understand why anyone cared about my uterus and what I did with it.' As the TV presenter sees it, one of the many upsides of being child-free is having the freedom and funds to travel. The former Today Extra panellist reveals how she got through 'dark times' and rebuilt herself. Picture: Supplied She and her husband, Darren Robinson, whom she met 'the old-fashioned way' in a bar in 2013, renew their wedding vows in every country they visit. In 10 years of marriage, that's 25 vow renewals. 'Sometimes it's been incredibly romantic in the Maldives with the sunset. Then we nearly forgot in Iceland and we did it on the plane as we were taking off,' she laughs. They also run their production company together, Robinson behind the camera ('the workhorse') Horton in front ('the show pony'). She says their two rescue dogs were a salve during her three years of depression. 'My wonderful husband would put me to bed and hand me a puppy.' Adhering to her motto of 'adapt or die', Horton's career trajectory has been 'eclectic'. She was a producer for the first American Survivor in Borneo, a crime then health reporter for the ABC, Sydney gossip columnist, panellist on Today Extra, and host of Married at First Sight's spin-off TV show. It's a long way from home for the girl from Kingaroy in regional Queensland. 'From the red soil to the red carpet,' she says. Now she can add author to the list, documenting her harrowing menopause experience – along with evidence-based advice from experts – on paper to support other women going through it. Despite the turmoil of menopause, Horton reveals it has also helped her too. 'I wish I could just say, 'Slap on some HRT [hormone replacement therapy], you'll be fine', but it's not as simple as that,' she tells Stellar. 'I had to do the work. I had treated my body as a rental. 'I had to have the appointments with the psychiatrist. I had to change my lifestyle, improve my sleep, increase my exercise. 'I'm living proof that you can go through dark times and come out. Perimenopause broke me, but then I rebuilt me.' I'm Your Peri Godmother by Shelly Horton (Murdoch Books, $34.99) is out Tuesday. For more from Stellar and the podcast, Something To Talk About, click here. Originally published as 'I had treated my body as a rental': Media personality Shelly Horton reveals life-changing health message to Australian women

ABC News
10 hours ago
- ABC News
What's in your freezer?
Move the peas over to find that Australian freezers have seals, kangaroo penises and the DNA of 'the Chanel of goats.' Featuring: Dr Natalie Warburton, Murdoch University. Dr Natalie Warburton, Murdoch University. Dr Jillian Garvey, La Trobe University. Dr Jillian Garvey, La Trobe University. Dr Nicola Rivers, Monash University. Dr Nicola Rivers, Monash University. Dianne Hakof, Hospital Manger Animal Health Department Zoos SA Production: Ann Jones, Presenter / Producer. Ann Jones, Presenter / Producer. Petria Ladgrove, Producer. This episode of What the Duck?! was first broadcast in 2022 and was produced on the land of the Wadawarrung and the Kaurna people. Stream the brand-new series Dr Ann's Secret Lives on ABC iview.

AU Financial Review
16 hours ago
- AU Financial Review
World-leading MDMA production kicks off in Australia
Safe, domestically produced MDMA might be the dream for Australian ravers, but it is now a reality for people with treatment-resistant post-traumatic stress disorder after Melbourne-based psychedelics manufacturer Cortexa finished its first production run of 10,000 capsules. In an Australian first, Cortexa has synthesised the world's largest single batch of high-quality therapeutic MDMA, an undertaking two years in the making and produced under high-level security.